The fund aims to provide capital appreciation.
Name | % Net Assets |
---|---|
STANDARD LIFE TM PACIFIC BASIN | 8.0% |
HSBC | 3.6% |
BP | 3.2% |
VODAFONE | 2.5% |
GlaxoSmithKline | 2.4% |
RIO TINTO | 1.8% |
Barclays | 1.5% |
British American Tobacco | 1.4% |
AstraZeneca | 1.3% |
Rio Tinto | 1.1% |
Key | % Net Assets |
---|---|
STANDARD LIFE TM PACIFIC BASIN | 8.0% |
HSBC | 3.6% |
BP | 3.2% |
VODAFONE | 2.5% |
Other | 82.7% |
Date | 21-Nov-2024 |
---|---|
NAV | 461.90p |
Currency | GBP |
Change | 0.40p |
% | 0.09% |
YTD change | 33.20p |
YTD % | 7.74% |
Fund Inception | 01/05/1986 |
---|---|
Fund Manager | Jacqueline Kerr |
TER | 0.61 (28-Sep-2012) |
Minimum Investment | |
---|---|
Initial | £250000 |
Additional | £50,000 |
Savings | n/a |
Charges | |
---|---|
Initial | n/a |
Annual Mang't | 0.50% |
Exit | n/a |
Name | % |
---|---|
Standard deviation | 0.02 |
Sharpe ratio | 0.07 |
You are here: research